Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2026
      • Dates and Deadlines
      • Exhibits
      • Housing and Travel
      • Call for Abstracts
      • Sessions and Events
      • Registration
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2025
      • Neuroscience 2024
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (1)
  • (1)
  • (4)
  • (74)
  • (4)
Filter
21 - 30 of 109 results
  • Abstract
    MARIJUANA EFFECTS ON ATTENTION AND rCBF.
    We previously assessed rCBF following smoking of marijuana and placebo as subjects repeatedly performed the same cognitive task. The task provided a stable cognitive baseline but did not allow assessment of direct vs task-related effects of marijuana. The present doubly-blinded study used PET with [O-15]water to measure rCBF in 12 volunteers who smoked marijuana or placebo cigarettes on 2 occasions at least a week apart. On each occasion subjects were imaged after smoking a marijuana (~20 mg THC) or placebo cigarette while performing 3 auditory tasks; a baseline RT task (also presented before smoking), and dichotic listening tasks with attend-right and attend-left ear instructions. As in our previous studies, smoking marijuana resulted in intoxication (self report), increased rCBF in orbital frontal cortex, anterior cingulate, temporal pole, insula, and cerebellum, and reduced rCBF in auditory and visual cortices. These changes occurred in all 3 tasks and appear to be direct effects of marijuana on rCBF. T...
    Nov 14, 2001
  • Abstract
    EFFECT OF Δ9-TETRAHYDROCANNABINOL (Δ9-THC) ON THE SINGLE-UNIT ACTIVITY OF SEROTONERGIC DORSAL RAPHE NEURONS IN FREELY MOVING CATS.
    Brain serotonin has been implicated in the action of many psychoactive drugs. One agent of particular social and medical interest is Δ9-THC, the major active constituent in marijuana. Although a number of studies have characterized the effect of Δ9-THC on various neurochemical indices of serotonergic function, none has directly examined the effect of this compound on the electrophysiological activity of serotonergic neurons. To determine whether Δ9-THC alters serotonergic neuronal activity, we monitored the firing rate of serotonergic dorsal raphe neurons in behaving animals acutely treated with this agent. Serotonergic neurons were identified and recorded as described previously (Fornal et al., 2001). Systemic administration of Δ9-THC (5 mg/kg, i.p.) produced clear signs of sedation and impaired motor function, which are established characteristics of THC's action. These behavioral effects were evident within 15-30 min after injection and persisted for several hours. During periods when the cats were clea...
    Nov 6, 2002
  • Abstract
    The subjective response to delta-9-tetrahydrocannabinol (THC) is modulated by activation of endogenous opioid systems in rats.
    Several pharmacological effects of delta-9-tetrahydrocannabinol (THC) are reduced or blocked by administration of opioid antagonists and rewarding or aversive properties of THC are modified in mice lacking opioid receptors. In this study, rats learned to discriminate a 3 mg/kg i.p. injection of THC from an injection of vehicle under a two-lever choice procedure with food reinforcement. We then investigated whether the subjective effects of THC could be blocked or reduced by administration of opioid antagonists and whether opioid agonists could mimic or potentiate THC’s subjective effects. The opioid antagonist naloxone (1 mg/kg, i.p.) produced a small decrease in the discriminative effects of the training dose of 3 mg/kg THC and significantly shifted the THC dose-response curve to the right. When the opioid agonist morphine (1-10 mg/kg, i.p.) was substituted for THC, it did not produce THC-like discriminative effects. However, a 1 mg/kg dose of morphine potentiated the discriminative effects of THC, shifti...
    Nov 11, 2003
  • Abstract
    DOSE-DEPENDENT EFFECTS OF TETRAHYDROCANNABINOL (THC) ON BRAIN ACTIVITY IN HUMANS: A FUNCTIONAL MAGNETIC RESONANCE IMAGING (fMRI) STUDY.
    A characteristic pattern of behavioral and physiological effects is produced by marijuana and its principal psychoactive component, THC, in humans. However, THC’s sites of action in the human brain and their relationships to the drug’s actions are not well described. We have now studied in frequent marijuana users, the effects of two doses of THC (1 and 3 mg iv over 1 min) that produce effects similar to those seen with marijuana use in a social situation, on regional brain activity using BOLD fMRI. The subjects reported that the intensity of the “high” produced by the 3 mg dose was twice that of the lower dose (8/10 vs. 4.5/10). A modest dose-related tachycardia was also observed.Both increases and decreases in brain activity as measured by BOLD fMRI were seen in discrete brain regions. The 3 mg dose of THC produced time-related decreases in fMRI signal in the cerebellum including the region of the dentate nucleus, the middle temporal gyrus and the orbitofrontal region. Decreases were also seen in several...
    Nov 13, 2001
  • Abstract
    Marijuana and timing: Effects of chronic use.
    Altered time perception is one of the most frequently-reported subjective experiences associated with the “high” induced by marijuana (MJ). Intoxicated subjects typically experience time as passing more quickly relative to real time i.e., MJ increases the subjective time rate. We assessed the acute and chronic effects of smoking MJ or placebo cigarettes (provided by NIDA) on a self-paced finger tapping task using a double-blind, placebo-control design. Volunteers (n = 10) who smoked marijuana recreationally an average of 3 times a month (low-use group) were compared with chronic users (n = 15) who smoked marijuana daily for an average duration of 5 years. A tone was presented for 50s with a beat to beat interval of 730ms, and was then turned off. Subjects were instructed to tap in time with the tone and to continue tapping at the same pace for 50s after it terminated. Tone-paced tapping did not change in either group after smoking placebo or MJ, indicating that MJ did not cause sensory-motor impairment on ...
    Oct 26, 2004
  • Cannabidiol Inhibition of Murine Primary Nociceptors: Tight Binding to Slow Inactivated States of Nav1.8 Channels | Journal of Neuroscience
    The nonpsychoactive phytocannabinoid cannabidiol (CBD) has been shown to have analgesic effects in animal studies but little is known about its mechanism of action. We examined the effects of CBD on intrinsic excitability of primary pain-sensing neurons. Studying acutely dissociated capsaicin-sensitive mouse DRG neurons at 37°C, we found that CBD effectively inhibited repetitive action potential firing, from 15–20 action potentials evoked by 1 s current injections in control to 1–3 action potentials with 2 μm CBD. Reduction of repetitive firing was accompanied by a reduction of action potential height, widening of action potentials, reduction of the afterhyperpolarization, and increased propensity to enter depolarization block. Voltage-clamp experiments showed that CBD inhibited both TTX-sensitive and TTX-resistant (TTX-R) sodium currents in a use-dependent manner. CBD showed strong state-dependent inhibition of TTX-R channels, with fast binding to inactivated channels during depolarizations and slow unbin...
    Jul 28, 2021 Han-Xiong Bear Zhang
  • Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity | Journal of Neuroscience
    Excitotoxicity is a paradigm used to explain the biochemical events in both acute neuronal damage and in slowly progressive, neurodegenerative diseases. Here, we show in a longitudinal magnetic resonance imaging study that Δ9-tetrahydrocannabinol (Δ9-THC), the main active compound in marijuana, reduces neuronal injury in neonatal rats injected intracerebrally with the Na+/K+-ATPase inhibitor ouabain to elicit excitotoxicity. In the acute phase Δ9-THC reduced the volume of cytotoxic edema by 22%. After 7 d, 36% less neuronal damage was observed in treated rats compared with control animals. Coadministration of the CB1 cannabinoid receptor antagonist SR141716 prevented the neuroprotective actions of Δ9-THC, indicating that Δ9-THC afforded protection to neurons via the CB1 receptor. In Δ9-THC-treated rats the volume of astrogliotic tissue was 36% smaller. The CB1 receptor antagonist did not block this effect. These results provide evidence that the cannabinoid system can serve to protect the brain against neu...
    Sep 1, 2001 M. van der Stelt
  • Abstract
    CHRONIC Δ-9-TETRAHYDROCANNABINOL EXPOSURE INDUCES PERSISTENT ATTENTIONAL DEFICITS.
    The abuse of Δ-9-tetrahydrocannabinol (THC), the principal psychoactive constituent of marijuana, is associated with persistent cognitive dysfunction. We therefore studied the effects of chronic administration of THC (10 mg/kg) on cognitive function in the rat. THC administration, twice daily for 14 days, resulted in a persistent attentional impairment that is reminiscent of cognitive deficits observed following excitotoxic lesions of the dorsomedial frontal cortex. Specifically, rats chronically administered THC showed subsequent impairments in a self-paced version of the classic 5-choice serial reaction time task, which persisted 14 days after the final drug administration. Longer time points have yet to be examined. These attentional impairments were temporarily reversible by an acute amphetamine (0.5 mg/kg) challenge. Importantly, the attentional deficit was observed after withdrawal from THC, suggesting that the behavioral effects were drug-induced changes in the brain rather than a direct effect of T...
    Nov 6, 2002
  • Abstract
    Altered regional blood volume in chronic marijuana smokers.
    Marijuana remains the most commonly abused illicit substance in the United States, however, the effects of cannabis on cerebral blood volume (CBV) have not been fully examined. Given reported changes in frontal BOLD activation in marijuana smokers the objective of the present study was to examine both cerebral (frontal and temporal areas) and cerebellar blood volume during a period of supervised abstinence. Dynamic susceptibility contrast (DSC) MRI data were collected on eleven current, long-term marijuana users (MJ) between 6 hours and 36 hours after the subject's last reported cannabis use. Resting state CBV images were also acquired in 11 healthy comparison subjects (NCs). Data were acquired in the axial plane following a bolus of gadolinium contrast agent with a 1.5-Tesla GE Signa scanner. MJ smokers demonstrated significantly increased blood volumes in the left temporal area (p= 0.018) and in the cerebellum (p= 0.023) relative to control subjects. A regression analysis revealed that age was not signif...
    Nov 14, 2005
  • Abstract
    Estradiol enhances antinociceptive and motoric effects of THC.
    We have previously shown that cannabinoid agonists, including delta-9-tetrahydrocannabinol (THC), are more potent and in some cases more efficacious in female than in male rats, in terms of their antinociceptive and motoric effects (Tseng & Craft, Eur J Pharmacol 430:41, 2001). In the present study, we manipulated gonadal steroid hormone state in adulthood, to determine to what extent activational effects of gonadal steroids are responsible for sex differences in sensitivity to the behavioral effects of THC. Adult Sprague-Dawley rats were gonadectomized; half of the females were implanted s.c. with estradiol (1-mm capsule/rat), and half of the males were implanted with testosterone (10-mm capsule/100 g body weight), and the rest of the rats were implanted with blank capsules of comparable length and number. Three weeks later, rats were injected with THC (5 mg/kg i.p.) or vehicle (1:1:18 emulphor:ethanol:saline) and tested for antinociception (tail withdrawal and paw pressure tests) and motor behaviors (hor...
    Nov 13, 2005
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Featured

  • Explore the benefits of an SfN membership
  • Upcoming Webinar: Behavioral and Evolutionary Adaptations to Changing Environments
  • Seeburg Prize nominations have been extended to February 19
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience